Business

Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target

Sep 30, 2025 - 11:00
 1
Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target
Read More

Related Posts

Argentina suspends Telecom's purchase of Telefonica unit

Argentina suspends Telecom's purchase of Telefonica unit

Mar 21, 2025  2

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  3

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025  0

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025  0

Elon Musk says DOGE cuts necessary, but face headwinds according to Fox poll

Elon Musk says DOGE cuts necessary, but face headwinds ...

Mar 21, 2025  0

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025  3